comparemela.com

Latest Breaking News On - Syndax pharmaceuticals - Page 13 : comparemela.com

Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) Stake Boosted by Algert Global LLC

Algert Global LLC increased its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 79.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 456,219 shares of the company’s stock after purchasing an additional 202,588 shares during the period. […]

Hong kongUnited statesStifel nicolausQuarter for syndax pharmaceuticalsSyndax pharmaceuticalsRoyal bankChina universal asset management coSyndax pharmaceuticals tradingAmeritas investment partners incNews ratings for syndax pharmaceuticals dailyAlgert globalHong kong ltdSyndax pharmaceuticals incExchange commissionFree reportUniversal asset management

Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024

Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sharon klahreSyndax pharmaceuticals incPrnewswire syndax pharmaceuticalsSyndax pharmaceuticalsInternational numberDial in number

Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024

/PRNewswire/ Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today.

Sharon klahreSyndax pharmaceuticals incPrnewswire syndax pharmaceuticalsSyndax pharmaceuticalsInternational numberDial in number

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today.

Sharon klahreSyndax pharmaceuticals incSyndax pharmaceuticalsCompany on twitter

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Sharon klahreCompany on twitterSyndax pharmaceuticalsSyndax pharmaceuticals inc

vimarsana © 2020. All Rights Reserved.